Education in Biosimilars – Whitepaper

Reports on biosimilar medicines


Document, prepared by Samsung Bioepis that highlights the need for comprehensive training of health professionals and patients for better adherence to treatments with biosimilar drugs.

BioSim Newsletter

Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.

SUBSCRIBE